US Patent Issued to KYOTO UNIVERSITY, Takeda Pharmaceutical on Aug. 11 for "Hematopoietic progenitor cell marker" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,852, issued on Aug. 11, was assigned to KYOTO UNIVERSITY (Kyoto, Japan) and Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Hematopoietic progenitor cell marker" was invented by Shin Kaneko (Kyoto, Japan), Shoichi Iriguchi (Kyoto, Japan), Yuta Mishima (Kyoto, Japan), Yoshiaki Kassai (Kanagawa, Japan), Akira Hayashi (Kanagawa, Japan) and Suguru Arima (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method for producing a CD4/CD8 double positive cell, including the following steps: step 1: separating, from a cell population containing a hematopoietic progenitor cell, a cell expressing one or more kinds of molecules selecte...